ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,892Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 169

$1.28M Total Retail Price of All Prescriptions

Rank: 1 out of 169

733 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 733 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

5% of this provider’s 733 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

3% of this provider’s 8,768 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 47%.

Prescription Price

$117 was the average price of a prescription from this provider, compared to $148 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SYNTHROID 545 479 1 2
HUMULIN N 461 361 10 2 36
METFORMIN HCL 458 386 3 3
LEVOTHYROXINE SODIUM 442 320 4 1
NOVOLOG 411 290 5 17
HUMALOG 365 285 6 7
INSULIN SYRINGE 310 244 7 10
LANTUS 286 205 8 6
AMLODIPINE BESYLATE 280 258 9 16
SIMVASTATIN 273 252 10 8
BYETTA 260 182 10 11 29
NOVOLIN N 210 148 12 66
ATORVASTATIN CALCIUM 206 169 13 14
LISINOPRIL 206 140 13 12
PEN NEEDLE 177 120 15 4
ENALAPRIL MALEATE 173 162 16 71
WARFARIN SODIUM 162 133 17 49
GLYBURIDE 159 154 R 18 63
FUROSEMIDE 151 115 19 23
NOVOLOG FLEXPEN 149 110 20 11
HYDROCHLOROTHIAZIDE 149 120 20 28
LEVEMIR 138 114 22 72
METOPROLOL TARTRATE 129 120 23 33
JANUVIA 120 113 24 13
LOVASTATIN 117 90 25 67
OMEPRAZOLE 100 92 26 32
LANTUS SOLOSTAR 94 69 27 5
HUMULIN R 92 61 28 38
LOSARTAN POTASSIUM 91 88 29 20
ALPRAZOLAM 91 91 29 140
ACARBOSE 90 68 31 89
GLIMEPIRIDE 81 66 32 9
ACTOS 76 66 33 27
SPIRONOLACTONE 70 63 34 68
GEMFIBROZIL 68 67 35 114
ATENOLOL 66 44 36 50
POTASSIUM CHLORIDE 65 56 37 52
LEVEMIR FLEXPEN 64 55 38 21
GLIPIZIDE 61 51 39 31
PRAVASTATIN SODIUM 57 44 40 19
GABAPENTIN 57 42 40 25
CALCITRIOL 54 54 42 42
ALLOPURINOL 54 42 42 53
VICTOZA 3-PAK 53 17 44 39
TRAZODONE HCL 53 40 44 87
CRESTOR 51 50 46 22
PROPYLTHIOURACIL 50 38 47 189
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 10, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.